“Cognitively Accessible” Rx Labeling Tested By FDA Risk Cmte. Member Day
Executive Summary
"Cognitively accessible" prescription drug labeling could reduce medical errors by as much as 80%, according to a forthcoming study by FDA drug safety advisory committee member Ruth Day, PhD